June 20, 2021
Business News

TYME Appoints Frank L. Porfido as Chief Financial Officer

BEDMINSTER, N.J.–()–TYME Technologies, Inc. (Nasdaq: TYME) (the “Company” or “Tyme”), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™), today announced that it has appointed Frank L. Porfido as its Chief Financial Officer, effective shortly after the Company files its annual report on Form 10-K.

Mr. Porfido is a well-established biotech and pharmaceutical industry executive with over 25 years of strategic financial leadership expertise. Throughout his career, Mr. Porfido has demonstrated a track record of building and leading cross-functional teams. Collectively, he spent over 15 years at Novartis in various leadership roles, including serving as the Global Head…

Click here to view the original article.

Related Posts

You might also like ...

Best Prime Day Toys Deals 2021: Early Board Games, Baby Toys, Osmo, LeapFrog & More Sales Rounded Up by Consumer Articles
AON Splash Image
Prime Day Smart TV Deals (2021): Early Samsung, LG, Sony, TCL, Sharp, Vizio & More Sales Identified by Deal Tomato
AON Splash Image
Best Fire Tablet & Kindle Prime Day Deals 2021: Early Fire HD (10, 8, 7), Kindle Paperwhite & Oasis Sales Found by Saver Trends